Bleomycin and Oxygen clinical decision support

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Fri, 12/06/2019 - 12:43
#1
Jessica Lassiter
Jessica Lassiter's picture
Offline
Last seen: 8 months 4 weeks ago
Joined: 06/14/2017 - 17:41
Bleomycin and Oxygen clinical decision support

Does your institution have clinical decision support or alerting to help prevent concomitant ordering of supplemental oxygen for patients on or have historically received bleomycin therapy? (increased risk of pulmonary toxicity/pulmonary fibrosis with supplemental oxygen combined with bleomycin)

Top